Clinical Trials Browser

Withdrawn × INDUSTRY × sacituzumab govitecan × Clear all

NCT02161679 2021-08-19

Phase II Study of IMMU-132 Alone or in Combination With Carboplatin in Patients With Triple-Negative Breast Cancer

Phase 2 Withdrawn

Triple Negative Breast Neoplasms